MeSH note : 6% hydroxyethylstarch (HES) with MW 130 kDa and a very low degree of substitution
(Ds 0.4); volume replacement with HES 130/0.4 may reduce the inflammatory response
in patients undergoing major abdominal surgery;
CISMeF synonym : hydroxyéthylamidon 130000; HEA 130/0,4; hydroxyéthylamidon 130/0,4; voluven;
http://www.has-sante.fr/jcms/c_1777260/fr/voluven http://www.has-sante.fr/jcms/c_1777260/fr/voluven-hydroxyethylamidon-solutes-de-remplissage-colloide http://www.has-sante.fr/jcms/c_399173/fr/voluven-solution-pour-perfusion-500-ml-en-poche-pvc-de-type-perfuflex-suremballee-boite-de-1-poche http://www.has-sante.fr/jcms/c_400348/fr/voluven-solution-pour-perfusion-poche-de-500-ml-pvc-de-type-perfuflex-suremballee-cip-356-738-0 2014 false true false France French evaluation of the transparency committee drug combinations sodium chloride HES 130-0.4 plasma substitutes infusions, intravenous hydroxyethylstarch treatment outcome hypovolemia Postoperative hypovolemic shock (disorder) postoperative hemorrhage guidelines for drug use hydroxyethyl starch derivatives
--- http://www.has-sante.fr/jcms/c_1777259/fr/restorvol 2014 true France French postoperative hemorrhage treatment outcome Postoperative hypovolemic shock (disorder) infusions, intravenous drug combinations sodium chloride HES 130-0.4 hydroxyethyl starch derivatives plasma substitutes hypovolemia hydroxyethylstarch evaluation of the transparency committee
--- http://www.has-sante.fr/jcms/c_1777265/fr/isovol 2014 false false false France French evaluation of the transparency committee infusions, intravenous plasma substitutes hypovolemia hemorrhage hydroxyethylstarch drug combinations sodium acetate malic acid calcium chloride magnesium chloride potassium chloride sodium chloride HES 130-0.4 postoperative complications Postoperative hypovolemic shock (disorder) malates hydroxyethyl starch derivatives
--- http://www.has-sante.fr/jcms/c_812381/restorvol-6-hydroxyethylamidon http://www.has-sante.fr/jcms/c_677431/fr/restorvol 2008 false France French infusions, intravenous sodium chloride HES 130-0.4 treatment outcome drug combinations hydroxyethyl starch derivatives plasma substitutes hypovolemia hydroxyethylstarch evaluation of the transparency committee guidelines for drug use
Manual NTBT mappings (CISMeF)